Biosimilar DMARDs Offer Cost-Effective Option for Patients With RA After Failed Methotrexate Treatment

Press/Media

Period15 Jul 2024

Media coverage

1

Media coverage

  • TitleBiosimilar DMARDs Offer Cost-Effective Option for Patients With RA After Failed Methotrexate Treatment
    Media name/outletCenter for Biosimilars, The
    Country/TerritoryUnited States
    Date15/07/24
    PersonsKA HOU CHAN
View all 1
View less